Access the full text.
Sign up today, get DeepDyve free for 14 days.
Bramahn Singh, S. Connolly, H. Crijns, D. Roy, P. Kowey, A. Capucci, D. Radzik, E. Aliot, S. Hohnloser (2007)
Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter.The New England journal of medicine, 357 10
I. Gelder, V. Hagens, J. Kingma, H. Bosker, O. Kamp, T. Kingma, N. Veeger, J. Bouma, E. Tenvergert, J. Tijssen, H. Crijns (2002)
Rate control versus electrical cardioversion for atrial fibrillation: A randomised comparison of two treatment strategies concerning morbidity, mortality, quality of life and cost-benefit - the RACE study design.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 10 3
S. Hohnloser, K. Kuck, J. Lilienthal (2000)
Rhythm or rate control in atrial fibrillation—Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trialThe Lancet, 356
D Roy, M Talajic, S Nattel, DG Wyse, P Doria, KL Lee (2008)
Rhythm control versus rate control for atrial fibrillation and heart failureN Engl J Med, 358
Wei Sun, J. Sarma, Bramahn Singh (2002)
Chronic and Acute Effects of Dronedarone on the Action Potential of Rabbit Atrial Muscle Preparations: Comparison With AmiodaroneJournal of Cardiovascular Pharmacology, 39
L. Køber, C. Torp-Pedersen, J. McMurray, O. Gøtzsche, S. Lévy, H. Crijns, J. Amlie, J. Carlsen (2008)
Increased mortality after dronedarone therapy for severe heart failure.The New England journal of medicine, 358 25
D. Roy, Craig Pratt, C. Torp-Pedersen, D. Wyse, E. Toft, S. Juul-Moller, T. Nielsen, S. Rasmussen, Ian Stiell, B. Coutu, John Ip, Edward Pritchett, A. Camm (2008)
Vernakalant Hydrochloride for Rapid Conversion of Atrial Fibrillation: A Phase 3, Randomized, Placebo-Controlled TrialCirculation, 117
C. McGann, E. Kholmovski, R. Oakes, Joshua Blauer, M. Daccarett, N. Segerson, Kelly Airey, N. Akoum, E. Fish, Troy Badger, E. DiBella, D. Parker, R. Macleod, N. Marrouche (2008)
New magnetic resonance imaging-based method for defining the extent of left atrial wall injury after the ablation of atrial fibrillation.Journal of the American College of Cardiology, 52 15
D. Roy, M. Talajic, S. Nattel, D. Wyse, P. Dorian, Kerry Lee, M. Bourassa, Malcolm Arnold, Alfred Buxton, A. Camm, S. Connolly, M. Dubuc, A. Ducharme, P. Guerra, Stefan Hohnloser, J. Lambert, J. Heuzey, G. O'hara, Ole Pedersen, Lean-Lucien Rouleau, Bramah Singh, L. Stevenson, William Stevenson (2009)
Rhythm Control versus Rate Control for Atrial Fibrillation and Heart FailureYearbook of Cardiology, 2009
L. Hsu, P. Jaïs, P. Sanders, S. Garrigue, M. Hocini, F. Sacher, Y. Takahashi, M. Rotter, J. Pasquié, C. Scavée, P. Bordachar, J. Clémenty, M. Haïssaguerre (2004)
Catheter ablation for atrial fibrillation in congestive heart failure.The New England journal of medicine, 351 23
Michael Chen, N. Marrouche, Y. Khaykin, A. Gillinov, O. Wazni, David Martin, A. Rossillo, A. Verma, J. Cummings, D. Erciyes, E. Saad, M. Bhargava, Dianna Bash, R. Schweikert, D. Burkhardt, Michelle Williams-Andrews, Alejandro Perez‐Lugones, A. Abdul-Karim, W. Saliba, A. Natale (2004)
Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function.Journal of the American College of Cardiology, 43 6
N. Marrouche, J. Brachmann (2009)
Catheter Ablation versus Standard Conventional Treatment in Patients with Left Ventricular Dysfunction and Atrial Fibrillation (CASTLE‐AF) ‐ Study DesignPacing and Clinical Electrophysiology, 32
IC Van Gelder, VE Hagens, HA Boskar, JH Kingma, O Kamp, T Kingma (2002)
Rate control versus electrical cardioversion for persistent atrial fibrillation study group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillationN Engl J Med, 347
I. Gelder, V. Hagens, H. Bosker, J. Kingma, Otto Kamp, T. Kingma, Salah Said, Julius Darmanata, Alphons Timmermans, Jan Tijssen, H. Crijns (2002)
A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.The New England journal of medicine, 347 23
B. Lutomsky, T. Rostock, A. Koops, D. Steven, K. Müllerleile, H. Servatius, I. Drewitz, Denis Ueberschär, Thorsten Plagemann, R. Ventura, T. Meinertz, S. Willems (2008)
Catheter ablation of paroxysmal atrial fibrillation improves cardiac function: a prospective study on the impact of atrial fibrillation ablation on left ventricular function assessed by magnetic resonance imaging.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 10 5
C. Tondo, M. Mantica, G. Russo, A. Avella, L. Luca, A. Pappalardo, R. Fagundes, E. Picchio, F. Laurenzi, V. Piazza, Irma Bisceglia (2006)
Pulmonary Vein Vestibule Ablation for the Control of Atrial Fibrillation in Patients with Impaired Left Ventricular FunctionPacing and Clinical Electrophysiology, 29
D. Wyse, A. Waldo, J. Dimarco, M. Domanski, Y. Rosenberg, Eleanor Schron, J. Kellen, H. Greene, M. Mickel, J. Dalquist, S. Corley (2002)
A comparison of rate control and rhythm control in patients with atrial fibrillation.The New England journal of medicine, 347 23
NF Marrouche, J Brachmann (2009)
On behalf of the CASTLE-AF steering committee. Cather ablation versus standard conventional treatment in patients with left ventricular dysfunction and atrial fibrillation (CASTLE-AF)—study designPacing Clin Electrophysiol, 32
SM Sun, JSN Sarma, BN Singh (2002)
Chronic and acute effects of dronedarone on the action potential of atrial rabbit muscle: comparisons with amiodaroneJ Cardiovasc Pharmacol, 39
R. Oakes, Troy Badger, E. Kholmovski, N. Akoum, N. Burgon, E. Fish, Joshua Blauer, Swati Rao, E. DiBella, N. Segerson, M. Daccarett, Jessiciah Windfelder, C. McGann, D. Parker, R. Macleod, N. Marrouche (2009)
Detection and Quantification of Left Atrial Structural Remodeling With Delayed-Enhancement Magnetic Resonance Imaging in Patients With Atrial FibrillationCirculation, 119
DG Wyse, AL Waldo, JP Di Marco, MJ Domanski, Y Rosenberg, EB Schron (2002)
Atrial fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) investigators. A comparison of rate and rhythm control in patients with atrial fibrillationN Engl J Med, 347
E. Benjamin, Daniel Levy, S. Vaziri, R. D’Agostino, A. Belanger, P. Wolf (1994)
Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study.JAMA, 271 11
Affirm Investigators (2003)
Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug.Journal of the American College of Cardiology, 42 1
S. Scardi, C. Mazzone (2001)
[Rhythm or rate control in atrial fibrillation -- Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomized trial].Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology, 2 3
J. Piccini, V. Hasselblad, E. Peterson, J. Washam, R. Califf, D. Kong (2009)
Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation.Journal of the American College of Cardiology, 54 12
F. Wegener, J. Ehrlich, S. Hohnloser (2006)
Dronedarone: An Emerging Agent with Rhythm‐ and Rate‐Controlling EffectsJournal of Cardiovascular Electrophysiology, 17
C. Lafuente-Lafuente, S. Mouly, Miguel Longás-Tejero, I. Mahé, J. Bergmann (2006)
Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials.Archives of internal medicine, 166 7
B. Olshansky, L. Rosenfeld, A. Warner, A. Solomon, G. O’Neill, Arjun Sharma, E. Platia, G. Feld, T. Akiyama, M. Brodsky, H. Greene, Affirm Investigators (2004)
The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation.Journal of the American College of Cardiology, 43 7
G. Gronefeld, S. Hohnloser (2003)
Heart Failure Complicated by Atrial Fibrillation: Mechanistic, Prognostic, and Therapeutic ImplicationsJournal of Cardiovascular Pharmacology and Therapeutics, 8
Radiofrequency catheter ablation (RFCA) has been established as a curative alternative to antiarrhythmic drug (AAD) therapy in patients with supraventricular arrhythmias other than atrial fibrillation (AF). Many currently used AAD have limited efficacy and cause cardiac and extracardiac adverse effects. There is a need for new AADs with high efficacy and a favorable safety profile in AF patients. Dronedarone and vernakalant are promising new agents with a low risk profile up to date. Effectively restoring sinus rhythm is a crucial aspect in heart failure (HF) patients with AF. RFCA, including pulmonary vein isolation and other left and right atrial ablation targets, offers the possibility of long-term suppressive or curative therapy of AF. New antiarrhythmic drug and interventional concepts in AF and HF patients are discussed.
Clinical Research in Cardiology Supplements – Springer Journals
Published: Mar 16, 2010
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.